Cosa, you pose an excellent question and it is surprising that it hasn’t received more attention and discussion here. There are obviously cases where a share buyback makes sense, but not usually when you are a small company attempting to launch and grow a drug - your only drug.
I have to assume that these initiatives have some end goal which was not divulged to us but possibly became clear to management thru the SR.